Sentinel lymph node biopsy in endometrial cancer: meta-analysis of 26 studies
OBJECTIVE: The validity of the sentinel lymph node (SLN) procedure for the assessment of
nodal status in patients with endometrial cancer is unclear. We aimed to assess the …
nodal status in patients with endometrial cancer is unclear. We aimed to assess the …
Adaptor protein complexes and intracellular transport
The AP (adaptor protein) complexes are heterotetrameric protein complexes that mediate
intracellular membrane trafficking along endocytic and secretory transport pathways. There …
intracellular membrane trafficking along endocytic and secretory transport pathways. There …
Recent trends in surface treatment technologies for airframe adhesive bonding processing: a review (1995–2008)
SY Park, WJ Choi, HS Choi, H Kwon… - The Journal of …, 2010 - Taylor & Francis
Proper surface treatment technologies are prerequisite for achieving long-term service
capability through the adhesive bonding process. However, the current surface treatment …
capability through the adhesive bonding process. However, the current surface treatment …
Comparison of the accuracy of magnetic resonance imaging and positron emission tomography/computed tomography in the presurgical detection of lymph node …
HJ Choi, JW Roh, SS Seo, S Lee, JY Kim, SK Kim… - Cancer, 2006 - Wiley Online Library
BACKGROUND The objective of the current study was to determine the accuracy of
magnetic resonance imaging (MRI) and positron emission tomography/computed …
magnetic resonance imaging (MRI) and positron emission tomography/computed …
Avelumab alone or in combination with chemotherapy versus chemotherapy alone in platinum-resistant or platinum-refractory ovarian cancer (JAVELIN Ovarian 200) …
E Pujade-Lauraine, K Fujiwara, JA Ledermann… - The lancet …, 2021 - thelancet.com
Background Most patients with ovarian cancer will relapse after receiving frontline platinum-
based chemotherapy and eventually develop platinum-resistant or platinum-refractory …
based chemotherapy and eventually develop platinum-resistant or platinum-refractory …
Survival after hyperthermic intraperitoneal chemotherapy and primary or interval cytoreductive surgery in ovarian cancer: a randomized clinical trial
Importance Ovarian cancer has the highest mortality rate among gynecologic malignant
tumors. Data are lacking on the survival benefit of hyperthermic intraperitoneal …
tumors. Data are lacking on the survival benefit of hyperthermic intraperitoneal …
Quality of life and sexual problems in disease‐free survivors of cervical cancer compared with the general population
SY Park, DS Bae, JH Nam, CT Park… - … Journal of the …, 2007 - Wiley Online Library
BACKGROUND. The purpose of this study was to identify problems related to long‐term
quality of life (QOL) and sexual function in cervical cancer survivors. METHODS. The authors …
quality of life (QOL) and sexual function in cervical cancer survivors. METHODS. The authors …
[HTML][HTML] Secondary surgical cytoreduction for recurrent ovarian cancer
RL Coleman, NM Spirtos, D Enserro… - … England Journal of …, 2019 - Mass Medical Soc
Background Secondary surgical cytoreduction in women with platinum-sensitive, recurrent
epithelial ovarian, primary peritoneal, or fallopian-tube (“ovarian”) cancer is widely practiced …
epithelial ovarian, primary peritoneal, or fallopian-tube (“ovarian”) cancer is widely practiced …
NFκB activation is associated with its O-GlcNAcylation state under hyperglycemic conditions
The transcription factor NFκB is activated by phosphorylation and acetylation and plays
important roles in inflammatory and immune responses in the cell. Additionally …
important roles in inflammatory and immune responses in the cell. Additionally …
Pembrolizumab plus GX-188E therapeutic DNA vaccine in patients with HPV-16-positive or HPV-18-positive advanced cervical cancer: interim results of a single-arm …
Background Survival outcomes for patients with recurrent or advanced cervical cancer are
poor. Pembrolizumab has been approved for the treatment of recurrent or metastatic cervical …
poor. Pembrolizumab has been approved for the treatment of recurrent or metastatic cervical …